SEPTEMBER 23, 2024
Gohibic™ (vilobelimab): A Treatment Option For Critically Ill COVID-19 Patients
This article describes the standard of care for hospitalized patients with COVID-19 in need of supplemental oxygen and the use of vilobelimab as part of a treatment regimen, supported by clinical data for patients who meet the Emergency Use Authorization criteria.
Download to read this article in PDF format:
Gohibic (vilobelimab): A Treatment Option For Critically Ill COVID-19 Patients
This article is in PDF format and it requires Adobe Reader.
If you do not have Adobe Reader installed on your computer then please download and install from the link below.
Download Adobe Reader